Tilray Inc buy PapaSmurf
Start price
12.09.23
/
50%
€3.10
Target price
12.09.24
-
Performance (%)
-25.42%
Price
30.04.24
€2.32
Summary
This prediction is currently active. The price of Tilray Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.42%. This prediction currently runs until 12.09.24. The prediction end date can be changed by PapaSmurf at any time. PapaSmurf has 50% into this predictionTilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Tilray Inc | -14.105% | -14.105% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |